HCW Biologics Inc. Earnings Per Share (Basic)
HCW Biologics Inc. (HCWB) reported Earnings Per Share (Basic) of -$11.58 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- HCW Biologics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$11.58.
- HCW Biologics Inc. earnings per share, basic for the quarter ending 2026-03-31 was $1.39.
- HCW Biologics Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$1.02.
- HCW Biologics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$2.02.
- HCW Biologics Inc. earnings per share, basic for fiscal 2025 was -$10.63.
- HCW Biologics Inc. earnings per share, basic for fiscal 2024 was -$30.96.
- HCW Biologics Inc. earnings per share, basic for fiscal 2023 was -$0.70.
- HCW Biologics Inc. earnings per share, basic for fiscal 2022 was -$0.42.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$11.58 10-Q · filed 2026-08-14 | -$11.98 10-Q · filed 2026-08-14 | -$9.35 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$11.21 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | $1.39 10-Q/A · filed 2026-08-14 | $0.37 10-Q · filed 2026-05-14 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$3.09 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$10.98 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2025-12-31 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.83 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$10.11 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$10.63 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$2.02 10-Q · filed 2025-11-14 | -$13.01 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$11.34 10-Q · filed 2025-11-14 | -$23.37 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$40.72 10-Q · filed 2026-08-14 | -$6.79 10-Q · filed 2025-08-18 | -$59.14 10-Q · filed 2026-08-14 | -$9.86 10-Q · filed 2025-08-18 | -$34.38 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$34.68 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2025-03-31 | -$11.80 10-Q/A · filed 2026-08-14 | -$0.05 10-Q · filed 2025-05-15 | -$8.96 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$12.98 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$31.58 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2024-12-31 | -$3.19 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$7.26 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$22.95 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$30.96 10-K · filed 2026-03-31 | -$0.77 10-K · filed 2025-03-28 | |||
| 2024-09-30 | -$4.13 10-Q · filed 2025-11-14 | -$0.10 10-Q · filed 2024-11-14 | -$20.29 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$28.33 10-Q · filed 2025-11-14 | -$0.71 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | -$16.16 10-Q · filed 2025-08-18 | -$0.40 10-Q · filed 2024-08-14 | -$24.25 10-Q · filed 2025-08-18 | -$0.61 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | -$0.20 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | -$0.70 10-K · filed 2025-03-28 | |||||||
| 2023-09-30 | -$0.14 10-Q · filed 2024-11-14 | -$0.40 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | -$0.12 10-Q · filed 2024-08-14 | -$0.26 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$0.14 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | -$0.42 10-K/A · filed 2024-05-15 | |||||||
| 2022-09-30 | -$0.11 10-Q · filed 2023-11-14 | -$0.26 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$0.10 10-Q · filed 2023-08-11 | -$0.16 10-Q · filed 2023-08-11 | -$0.24 derived: net income ÷ weighted average shares · filed 2023-08-11 | -$0.38 derived: net income ÷ weighted average shares · filed 2023-08-11 | ||||
| 2022-03-31 | -$0.06 10-Q/A · filed 2023-08-10 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$0.47 derived: net income ÷ weighted average shares · filed 2023-08-10 | ||||
| 2021-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$0.45 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$0.69 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | -$0.14 10-Q · filed 2022-11-07 | -$0.42 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$0.74 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | -$0.66 10-Q · filed 2022-08-12 | -$1.34 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |